Name: Sensei Biotherapeutics, Inc. (SNSE) Financial Statements
Creator: FinSpry

Sensei Biotherapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Sensei Biotherapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.33	0.00	0.00	0.00
Cost of Revenue	0.55	0.00	0.00	0.00	0.00
Gross Profit	-0.55	0.33	0.00	0.00	0.00
Operating Expenses
Research & Development	18.63	18.30	30.38	21.66	11.19
Selling, General & Administrative	12.49	18.77	19.81	15.82	7.53
Operating Expenses	31.11	37.06	50.19	37.48	18.71
Operating Income	-31.66	-37.06	-50.19	-37.48	-18.71
Other Income/Expense
Interest Income	2.55	3.62	1.78	0.80	0.00
Interest Expense	0.09	0.14	0.22	0.67	-1.69
Other Income/Expense	1.51	-3.11	0.04	-1.36	1.00
Income
Income Before Tax	-30.16	-15.80	-48.59	6.53	-20.10
Income Tax Expense	0.00	-9.89	-10.35	-8.30	0.00
Net Income	-30.16	-34.10	-48.59	-36.79	-20.10
Net Income - Continuous Operations	-30.16	-34.10	-48.59	-36.79	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-29.52	-41.14	-47.02	7.89	-18.50
EBIT	-37.25	-43.85	-48.37	7.20	-18.71
Depreciation & Amortization	0.55	0.57	1.35	0.69	0.21
Earnings Per Share
Basic EPS	-1.00	-1.00	-32.00	-1.00	-251.00
Diluted EPS	-1.00	-1.00	-32.00	-1.00	-251.00
Basic Shares Outstanding	25.12	27.95	1.54	27.71	0.08
Diluted Shares Outstanding	25.12	27.95	1.54	1.39	0.08